Your browser is no longer supported. Please, upgrade your browser.
Settings
TFX Teleflex Incorporated daily Stock Chart
TFX [NYSE]
Teleflex Incorporated
IndexS&P 500 P/E48.11 EPS (ttm)7.77 Insider Own0.31% Shs Outstand46.53M Perf Week0.94%
Market Cap17.48B Forward P/E29.37 EPS next Y12.72 Insider Trans-0.68% Shs Float46.42M Perf Month6.32%
Income367.00M PEG4.01 EPS next Q3.05 Inst Own92.70% Short Float1.49% Perf Quarter-1.74%
Sales2.51B P/S6.97 EPS this Y133.70% Inst Trans-1.13% Short Ratio2.75 Perf Half Y2.98%
Book/sh69.55 P/B5.37 EPS next Y21.19% ROA5.60% Target Price408.91 Perf Year6.73%
Cash/sh7.43 P/C50.30 EPS next 5Y12.00% ROE11.90% 52W Range221.27 - 409.27 Perf YTD-0.74%
Dividend1.36 P/FCF71.55 EPS past 5Y19.10% ROI11.10% 52W High-8.70% Beta1.11
Dividend %0.36% Quick Ratio1.90 Sales past 5Y7.10% Gross Margin53.40% 52W Low68.87% ATR12.01
Employees14400 Current Ratio3.00 Sales Q/Q-3.10% Oper. Margin17.80% RSI (14)59.42 Volatility2.55% 3.56%
OptionableYes Debt/Eq0.66 EPS Q/Q-49.20% Profit Margin14.70% Rel Volume0.84 Prev Close381.62
ShortableYes LT Debt/Eq0.63 EarningsOct 29 BMO Payout17.20% Avg Volume252.39K Price373.66
Recom1.60 SMA205.72% SMA506.48% SMA2006.31% Volume211,661 Change-2.09%
Nov-02-20Upgrade KeyBanc Capital Markets Sector Weight → Overweight $382
Jan-31-20Reiterated Needham Buy $408 → $423
Aug-02-19Reiterated Needham Buy $325 → $403
Jun-11-19Initiated Wells Fargo Outperform $345
Apr-24-19Downgrade Needham Strong Buy → Buy $325
Feb-22-19Reiterated Needham Strong Buy $300 → $325
Oct-16-18Initiated Barclays Equal Weight $266
Sep-10-18Upgrade Needham Buy → Strong Buy $279 → $300
Aug-03-18Reiterated Needham Buy $298 → $279
May-14-18Reiterated Needham Buy $293 → $298
May-04-18Reiterated Needham Buy $285 → $293
Apr-04-18Initiated Goldman Neutral $257
Nov-10-17Resumed Piper Jaffray Overweight $295
Nov-03-17Reiterated Needham Buy $237 → $285
Sep-08-17Upgrade Leerink Partners Mkt Perform → Outperform
Sep-06-17Upgrade Morgan Stanley Equal-Weight → Overweight
Sep-06-17Reiterated Needham Buy $228 → $237
Mar-07-17Initiated Needham Buy $221
Jan-06-17Upgrade Jefferies Hold → Buy
Jul-12-16Downgrade KeyBanc Capital Mkts Overweight → Sector Weight
Nov-19-20 06:30AM  
Nov-17-20 10:03AM  
Nov-03-20 08:29AM  
Nov-02-20 11:29AM  
06:30AM  
Oct-29-20 07:45AM  
07:45AM  
06:45AM  
06:30AM  
Oct-28-20 05:00PM  
09:53AM  
06:30AM  
Oct-27-20 06:30AM  
Oct-22-20 12:33PM  
Oct-19-20 06:30AM  
Oct-08-20 06:30AM  
Oct-07-20 12:30PM  
Oct-05-20 09:59AM  
Oct-01-20 06:30AM  
Sep-28-20 10:54AM  
Sep-11-20 03:07PM  
Sep-02-20 06:30AM  
Aug-29-20 11:32AM  
Aug-26-20 06:30AM  
Aug-24-20 01:12PM  
10:28AM  
Aug-18-20 06:30AM  
Jul-31-20 12:41PM  
Jul-30-20 06:00PM  
08:15AM  
06:45AM  
06:30AM  
06:00AM  
Jul-23-20 12:33PM  
Jul-21-20 06:30AM  
Jul-20-20 06:30AM  
Jul-14-20 06:30AM  
Jul-09-20 06:05PM  
Jun-23-20 06:30AM  
Jun-22-20 06:30AM  
Jun-17-20 11:20AM  
Jun-08-20 05:00PM  
Jun-05-20 12:17PM  
Jun-04-20 10:07AM  
Jun-03-20 06:45AM  
Jun-02-20 06:30AM  
May-30-20 11:31AM  
May-27-20 10:10AM  
May-21-20 05:00PM  
10:49AM  
08:49AM  
May-20-20 02:35PM  
May-18-20 06:30AM  
May-04-20 10:55AM  
06:45AM  
06:30AM  
Apr-30-20 06:30PM  
07:55AM  
06:30AM  
Apr-29-20 05:15PM  
05:00PM  
11:09AM  
06:45AM  
Apr-23-20 12:32PM  
Apr-20-20 05:00PM  
11:22AM  
Apr-17-20 06:45AM  
Apr-15-20 11:40AM  
Apr-02-20 09:23AM  
Mar-30-20 12:18PM  
Mar-21-20 11:30AM  
Mar-19-20 12:27AM  
Mar-16-20 10:51AM  
Mar-11-20 06:45AM  
Mar-03-20 08:13PM  
Feb-25-20 06:45AM  
Feb-24-20 09:03AM  
09:01AM  
Feb-20-20 08:05AM  
06:45AM  
06:30AM  
Feb-17-20 02:09PM  
10:04AM  
Feb-14-20 05:00PM  
Feb-13-20 05:00PM  
12:31PM  
Feb-06-20 06:45AM  
Jan-28-20 11:18AM  
Jan-22-20 06:30AM  
Jan-16-20 02:03PM  
Jan-14-20 06:30AM  
Jan-13-20 10:46AM  
Jan-10-20 08:38AM  
Jan-08-20 09:00AM  
Jan-07-20 06:30AM  
Jan-03-20 10:57AM  
Jan-02-20 09:40AM  
06:45AM  
Dec-30-19 06:45AM  
Dec-19-19 06:45AM  
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters and related devices, including catheter positioning systems for use in the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. The company also offers interventional products consist of various coronary catheters, structural heart therapies, and peripheral intervention and cardiac assist products that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded catheters, Guideline and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. It provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. The company also offers interventional urology product comprises the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; and respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings. It provides urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management for patients in the hospital and individuals in the home care markets. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. The company was founded in 1943 and is headquartered in Wayne, Pennsylvania.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Klasko Stephen K. M.D.DirectorOct 26Option Exercise58.2520011,6501,321Oct 28 08:24 AM
Klasko Stephen K. M.D.DirectorOct 26Sale361.3820072,2761,121Oct 28 08:24 AM
Klasko Stephen K. M.D.DirectorSep 25Option Exercise58.2520011,6501,321Sep 28 09:27 PM
Klasko Stephen K. M.D.DirectorSep 25Sale326.1520065,2301,121Sep 28 09:27 PM
Klasko Stephen K. M.D.DirectorAug 25Option Exercise58.2520011,6501,321Aug 26 04:41 PM
Klasko Stephen K. M.D.DirectorAug 25Sale373.7420074,7481,121Aug 26 04:41 PM
Klasko Stephen K. M.D.DirectorJul 27Option Exercise58.2520011,6501,321Jul 28 09:05 PM
Klasko Stephen K. M.D.DirectorJul 27Sale386.3520077,2701,121Jul 28 09:05 PM
Klasko Stephen K. M.D.DirectorJun 25Option Exercise58.2520011,6501,321Jun 26 04:41 PM
Klasko Stephen K. M.D.DirectorMay 26Option Exercise58.2520011,6501,321May 27 04:35 PM
Klasko Stephen K. M.D.DirectorMay 26Sale375.1420075,0281,121May 27 04:35 PM
Hicks Cameron PCorp. VP, HR & CommunicationsMay 11Option Exercise92.4190783,8178,157May 11 05:20 PM
Hicks Cameron PCorp. VP, HR & CommunicationsMay 07Option Exercise85.541,400119,7568,650May 11 05:20 PM
Hicks Cameron PCorp. VP, HR & CommunicationsMay 07Sale343.571,400480,9987,250May 11 05:20 PM
Deren JohnVP & Chief Accounting OfficerMay 05Sale330.101,093360,797986May 07 05:17 PM
Klasko Stephen K. M.D.DirectorApr 27Option Exercise58.2520011,650938Apr 28 05:07 PM
Klasko Stephen K. M.D.DirectorApr 27Sale342.2620068,452738Apr 28 05:07 PM
Klasko Stephen K. M.D.DirectorMar 25Option Exercise58.2520011,650938Mar 26 12:54 PM
Klasko Stephen K. M.D.DirectorMar 25Sale254.7520050,950738Mar 26 12:54 PM
Deren JohnVP & Chief Accounting OfficerFeb 28Option Exercise218.932,184478,1384,263Mar 03 04:15 PM
Deren JohnVP & Chief Accounting OfficerFeb 28Sale346.172,184756,0352,079Mar 03 04:15 PM
Leyden James JVP, General Counsel, SecretaryFeb 27Option Exercise61.343,200196,28817,341Feb 27 07:49 PM
Leyden James JVP, General Counsel, SecretaryFeb 27Sale344.28750258,20715,886Feb 27 07:49 PM
Klasko Stephen K. M.D.DirectorFeb 25Option Exercise58.2520011,650938Feb 26 01:36 PM
Klasko Stephen K. M.D.DirectorFeb 25Sale360.9520072,190738Feb 26 01:36 PM
Klasko Stephen K. M.D.DirectorJan 27Option Exercise58.2520011,650936Jan 28 02:56 PM
Klasko Stephen K. M.D.DirectorJan 27Sale375.7120075,142736Jan 28 02:56 PM
Klasko Stephen K. M.D.DirectorDec 26Option Exercise61.3420012,268936Dec 26 05:43 PM
Klasko Stephen K. M.D.DirectorDec 26Sale374.3520074,870736Dec 26 05:43 PM
Hicks Cameron PVice President, Global HRNov 29Option Exercise85.541,00085,5407,106Dec 02 04:09 PM
affiliate | advertise | contact | privacy | help
Do not sell my personal information

Quotes delayed 15 minutes for NASDAQ, and 20 minutes for NYSE and AMEX.
Copyright © 2007-2020 FINVIZ.com. All Rights Reserved.